-
Something wrong with this record ?
Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase
A. Skarka, L. Skarydová, H. Stambergová, V. Wsól,
Language English Country Ireland
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- MeSH
- Alcohol Oxidoreductases metabolism MeSH
- Anthracyclines metabolism MeSH
- Biotransformation MeSH
- Cell Membrane enzymology metabolism MeSH
- Microsomes, Liver enzymology metabolism MeSH
- Humans MeSH
- Antineoplastic Agents metabolism MeSH
- Substrate Specificity MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
Anthracyclines (ANTs) are widely used in the treatment of various forms of cancer. Although their usage contributes to an improvement in life expectancy, it is limited by severe adverse effects-acute and chronic cardiotoxicity. Several enzymes from both AKR and SDR superfamilies have been reported as participants in the reduction of ANTs. Nevertheless all of these are located in the cytosolic compartment. One microsomal reductase has been found to be involved in the metabolism of xenobiotics-11beta-HSD1, but no further information has been reported about its role in the metabolism of ANTs. The aim of this study is to bring new information about the biotransformation of doxorubicin (DOX), daunorubicin (DAUN) and idarubicin (IDA), not only in human liver microsomal fraction, but also by a novel human liver microsomal carbonyl reductase that has been purified by our group. The reduction of ANTs at C-13 position is regarded as the main pathway in the biotransformation of ANTs. However, our experiments with human liver microsomal fraction show different behaviour, especially when the concentration of ANTs in the incubation mixture is increased. Microsomal fraction was incubated with doxorubicin, daunorubicin and idarubicin. DOX was both reduced into doxorubicinol (DOXOL) and hydrolyzed into aglycone DOX and then subsequently reduced. The same behaviour was observed for the metabolism of DAUN and IDA. The activity of hydrolases definitely brings a new look to the entire metabolism of ANTs in microsomal fraction, as formed aglycones undergo reduction and compete for the binding site with the main ANTs. Moreover, as there are two competitive reducing reactions present for all three ANTs, kinetic values of direct reduction and the reduction of aglycone were calculated. These results were compared to previously published data for human liver cytosol. In addition, the participation of the newly determined human liver microsomal carbonyl reductase was studied. No reduction of DOX into DOXOL was detected. Nevertheless, the involvement in reduction of DAUN into DAUNOL as well as IDA into IDAOL was demonstrated. The kinetic values obtained were then compared with data which have already been reported for cytosolic ANTs reductases.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027903
- 003
- CZ-PrNML
- 005
- 20121207104723.0
- 007
- ta
- 008
- 120817s2011 ie f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cbi.2010.12.016 $2 doi
- 035 __
- $a (PubMed)21185270
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Skarka, Adam $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic.
- 245 10
- $a Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase / $c A. Skarka, L. Skarydová, H. Stambergová, V. Wsól,
- 520 9_
- $a Anthracyclines (ANTs) are widely used in the treatment of various forms of cancer. Although their usage contributes to an improvement in life expectancy, it is limited by severe adverse effects-acute and chronic cardiotoxicity. Several enzymes from both AKR and SDR superfamilies have been reported as participants in the reduction of ANTs. Nevertheless all of these are located in the cytosolic compartment. One microsomal reductase has been found to be involved in the metabolism of xenobiotics-11beta-HSD1, but no further information has been reported about its role in the metabolism of ANTs. The aim of this study is to bring new information about the biotransformation of doxorubicin (DOX), daunorubicin (DAUN) and idarubicin (IDA), not only in human liver microsomal fraction, but also by a novel human liver microsomal carbonyl reductase that has been purified by our group. The reduction of ANTs at C-13 position is regarded as the main pathway in the biotransformation of ANTs. However, our experiments with human liver microsomal fraction show different behaviour, especially when the concentration of ANTs in the incubation mixture is increased. Microsomal fraction was incubated with doxorubicin, daunorubicin and idarubicin. DOX was both reduced into doxorubicinol (DOXOL) and hydrolyzed into aglycone DOX and then subsequently reduced. The same behaviour was observed for the metabolism of DAUN and IDA. The activity of hydrolases definitely brings a new look to the entire metabolism of ANTs in microsomal fraction, as formed aglycones undergo reduction and compete for the binding site with the main ANTs. Moreover, as there are two competitive reducing reactions present for all three ANTs, kinetic values of direct reduction and the reduction of aglycone were calculated. These results were compared to previously published data for human liver cytosol. In addition, the participation of the newly determined human liver microsomal carbonyl reductase was studied. No reduction of DOX into DOXOL was detected. Nevertheless, the involvement in reduction of DAUN into DAUNOL as well as IDA into IDAOL was demonstrated. The kinetic values obtained were then compared with data which have already been reported for cytosolic ANTs reductases.
- 650 _2
- $a alkoholoxidoreduktasy $x metabolismus $7 D000429
- 650 _2
- $a antracykliny $x metabolismus $7 D018943
- 650 _2
- $a protinádorové látky $x metabolismus $7 D000970
- 650 _2
- $a biotransformace $7 D001711
- 650 _2
- $a buněčná membrána $x enzymologie $x metabolismus $7 D002462
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a jaterní mikrozomy $x enzymologie $x metabolismus $7 D008862
- 650 _2
- $a substrátová specifita $7 D013379
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Skarydová, Lucie
- 700 1_
- $a Stambergová, Hana
- 700 1_
- $a Wsól, Vladimír
- 773 0_
- $w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 191, č. 1-3 (2011), s. 66-74
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21185270 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121207104757 $b ABA008
- 999 __
- $a ok $b bmc $g 949945 $s 785249
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 191 $c 1-3 $d 66-74 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
- LZP __
- $a Pubmed-20120817/11/03